
BP-3RA: The Triple Receptor Agonist
One peptide that activates GLP-1, GIP, and glucagon receptors — how the triple mechanism works, the Phase 2 obesity, diabetes, and liver-fat results, and safety data.
Read article →Mechanism of action overviews, research summaries, and reference protocols. Written for researchers and curious minds, not medical advice.
Ask a research question
One peptide that activates GLP-1, GIP, and glucagon receptors — how the triple mechanism works, the Phase 2 obesity, diabetes, and liver-fat results, and safety data.
Read article →
Seven common claims about TRT checked against the evidence — the TRAVERSE cardiovascular trial, mood and aggression research, prostate risk, fertility, and recovery after stopping.
Read article →
A selective MC4 receptor agonist that acts on the brain's arousal circuitry rather than blood flow — mechanism, the RECONNECT Phase 3 trials, safety data, and protocols reported in the literature.
Read article →
Summary of the July 23–24, 2026 Pharmacy Compounding Advisory Committee vote on BPC-157, KPV, TB-500, MOTS-c, DSIP, Semax, and Epitalon — what was recommended, what was rejected, and what happens next.
Read article →
A nonapeptide first isolated from rabbit cerebral venous blood — its proposed mechanisms in slow-wave sleep, HPA-axis modulation, and the human investigational protocols reported in the literature.
Read article →
SS-31, MOTS-c, NAD+ precursors (NMN/NR), and Humanin — mechanism, cited human and preclinical trials, and the reconstitution and dosing parameters actually reported in the literature.
Read article →
Why researchers stack two Russian-developed heptapeptides: dopaminergic focus and BDNF drive from Semax, GABAergic calm from Selank — in one intranasal protocol.
Read article →
A no-nonsense breakdown of acute vs. chronic inflammation, the mediators involved, and why resolution — not suppression — is the goal.
Read article →
A four-peptide research blend combining KPV, BPC-157, GHK-Cu, and TB-500 for converging effects on tissue repair, inflammation, and matrix remodeling.
Read article →
A mitochondria-targeted tetrapeptide that binds cardiolipin to preserve inner-membrane bioenergetics and reduce oxidative stress.
Read article →
Best practices for handling, reconstituting, and storing lyophilized research peptides.
Read article →
A summary of preclinical research on the tetrapeptide Epitalon and its effects on telomere biology.
Read article →
Russian-developed heptapeptides studied for anxiolytic, nootropic, and neurotrophic activity.
Read article →
From Exendin to BP-1RA, BP-2RA and BP-3RA — comparing mechanism and receptor selectivity.
Read article →
How CJC-1295, Sermorelin, and Tesamorelin differ in pharmacokinetics and GH-pulse modulation.
Read article →
An overview of the mechanism, half-life and research on a 15-amino-acid fragment derived from gastric juice protein.
Read article →All content in the BioPrime Knowledge Center is provided for educational and informational purposes only. It does not constitute medical advice and is not intended to diagnose, treat, cure, or prevent any disease. BioPrime products are sold strictly for in-vitro laboratory research conducted by qualified professionals.
Contact our team →